Cargando…
The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease
Alcoholic liver disease (ALD) encompasses hepatic steatosis, which may progress to alcoholic hepatitis, fibrosis, and cirrhosis. It remains a leading cause of morbidity and mortality in the US and worldwide. The severity of liver disease correlates with plasma levels of bacterial products in patient...
Autores principales: | Hartmann, Phillipp, Chen, Wei-Chung, Schnabl, Bernd |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468817/ https://www.ncbi.nlm.nih.gov/pubmed/23087650 http://dx.doi.org/10.3389/fphys.2012.00402 |
Ejemplares similares
-
Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder
por: Hartmann, Phillipp, et al.
Publicado: (2021) -
Editorial: The Microbiome in Hepatobiliary and Intestinal Disease
por: Hartmann, Phillipp
Publicado: (2022) -
Host-Microbiome Interactions in Alcoholic Liver Disease
por: Chen, Peng, et al.
Publicado: (2014) -
The leaky gut and the gut microbiome in sepsis – targets in research and treatment
por: Chancharoenthana, Wiwat, et al.
Publicado: (2023) -
Understanding the Role of the Gut Microbiome in Diabetes and Therapeutics Targeting Leaky Gut: A Systematic Review
por: Sadagopan, Aishwarya, et al.
Publicado: (2023)